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Asymmetric sulfoxidation by engineering the
heme pocket of a dye-decolorizing peroxidase†
Dolores Linde,‡a Marina Cañellas,‡bc Cristina Coscolín,§a Irene Davó-Siguero,a
Antonio Romero,a Fátima Lucas,bc Francisco J. Ruiz-Dueñas,a
Victor Guallar*bd and Angel T. Martínez*a
The so-called dye-decolorizing peroxidases (DyPs) constitute a new family of proteins exhibiting remark-
able stability. With the aim of providing them new catalytic activities of biotechnological interest, the heme
pocket of one of the few DyPs fully characterized to date (from the fungus Auricularia auricula-judae) was
redesigned based on the crystal structure available, and its potential for asymmetric sulfoxidation was eval-
uated. Chiral sulfoxides are important targets in organic synthesis and enzyme catalysis, due to a variety of
applications. Interestingly, one of the DyP variants, F359G, is highly stereoselective in sulfoxidizing methyl-
phenyl sulfide and methyl-p-tolyl sulfide (95–99% conversion, with up to 99% excess of the S enantiomer
in short reaction times), while the parent DyP has no sulfoxidation activity, and the L357G variant produces
both R and S enantiomers. The two variants were crystallized, and their crystal structures were used in mo-
lecular simulations to provide a rational explanation for the new catalytic activities. Protein energy land-
scape exploration (PELE) showed more favorable protein–substrate catalytic complexes for the above vari-
ants, with a considerable number of structures near the oxygen atom of the activated heme, which is
incorporated into the substrates as shown in 18O-labeling experiments, and improved affinity with respect
to the parent enzyme, explaining their sulfoxidation activity. Additional quantum mechanics/molecular me-
chanics (QM/MM) calculations were performed to elucidate the high stereoselectivity observed for the
F359G variant, which correlated with higher reactivity on the substrate molecules adopting pro-S poses at
the active site. Similar computational analyses can help introduce/improve (stereoselective) sulfoxidation
activity in related hemeproteins.
Introduction
There is increasing interest in the synthesis and use of mole-
cules containing stereogenic centers. The sulfur atom of sulf-
oxides bearing two different substituents is a chiral center,
since it adopts tetrahedral sp3 hybridization, with a lone
electron pair occupying the fourth quadrant. Chiral sulfoxides
have a wide range of applications, from chiral auxiliaries to
pharmaceuticals.1 Among enzymes of interest in chiral syn-
thesis,2 flavoenzymes (including Baeyer–Villiger mono-
oxygenases) and hemeperoxidases are used for sulfoxidation
reactions.3–5 Cytochrome P450 enzymes also catalyze sulfo-
xidations, but the requirement of an auxiliary flavin-
containing enzyme/domain (and a source of reducing power,
as in the case of NAD[P]H-dependent flavoenzymes) limits
their biotechnological applicability.6 The enzymatic produc-
tion of active S omeprazole, a multibillion dollar drug, by a
modified cyclohexanone monooxygenase is a good example of
these biotransformations.7
In peroxidases, the oxidation reaction is mediated by a
peroxygenase mechanism rather than a peroxidase mecha-
nism, and sulfoxidation of thioanisole (methyl-phenyl sulfide,
MPS) and methyl-p-tolyl sulfide (MTS) yielding the corre-
sponding sulfoxides has been used as a probe of oxygen
transfer to organic sulfides. In this way, sulfoxidation has been
reported for the well-known fungal chloroperoxidase (CPO)8–10
and horseradish peroxidase (HRP),10–12 as well as for other
haloperoxidases (including vanadium peroxidases),13 several
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animal peroxidases,14 and also for cytochrome c peroxidase
(CcP),15 Coprinopsis cinerea peroxidase (CiP),16 and lignin per-
oxidase (LiP),17 with different conversion rates and stereo-
selectivities. Recently, a robust peroxidase/peroxygenase of the
HTP protein superfamily has been described from the basidio-
mycete Agrocybe aegerita with predominant monooxygenase ac-
tivity (unspecific peroxygenase, UPO),18 which is able to selec-
tively convert MPS into the R enantiomer of methyl-phenyl
sulfoxide.19,20 Another UPO, from the related fungus
Coprinellus varians, is especially efficient in sulfoxidizing
dibenzothiophene.21
Although the natural substrate/s of the so-called dye-decol-
orizing peroxidases (DyPs), forming part of the new CDE pro-
tein superfamily,22 are still to be identified, these enzymes
present considerable catalytic versatility and exceptional sta-
bility under extreme pH, temperature, and even pressure con-
ditions.23,24 DyPs, as some fungal ligninolytic peroxidases of
the peroxidase–catalase superfamily (LiP and versatile peroxi-
dase), have the ability to oxidize substrates at two catalytic
sites, one located at an exposed protein radical and a second
one at the heme pocket, which has a more axial access in
DyPs than in ligninolytic and related peroxidases.25
In this work, we engineer the heme pocket of the
Auricularia auricula-judae DyP, one of the few members of
this new family fully characterized to date,26–28 with the aim
of providing new catalytic properties to the enzyme. The na-
tive recombinant DyP is unable to perform sulfoxidation reac-
tion, but interestingly, two individual mutations at the heme
pocket provide sulfoxidation activity on MPS and MTS. More
interestingly, one of them was stereoselectively forming the S
enantiomer, while the second variant yielded similar percent-
ages of both isomers. With the use of molecular modeling
techniques, we aim to provide a rational explanation at the
atomic level of the differences in yield and selectivity ob-
served during sulfoxidation of MPS and MTS by the native
DyP and its two heme pocket variants, whose crystal struc-
tures were solved.
Results and discussion
Experimental enzyme engineering and sulfoxidation reactions
The heme pockets of A. auricula-judae DyP and other peroxi-
dases were compared, and variants with enlarged access to
the enzyme cofactor were obtained and evaluated for sulfo-
xidation of two organic sulfides, as described in the next
three sections.
Redesigning the DyP heme pocket for sulfoxidation. A
comparison of the upper side of the heme pocket (where
Fe4+O is located in compound I after H2O2 activation) in
peroxidases from three different superfamilies is shown in
Fig. 1. In HRP (Fig. 1A), the so-called distal histidine occupies
an axial position (above the heme iron) contributing to the
reaction with H2O2 together with a neighbor arginine.
29 In
UPO (Fig. 1B), a glutamate/arginine couple plays a similar
function,30 while the couple is aspartate/arginine in DyP
(Fig. 1C).27
Due to their crucial role in the formation of reactive com-
pound I, site-directed mutagenesis of the above-mentioned
residues in A. auricula-judae DyP drastically decreased its cat-
alytic efficiency reducing H2O2 (measured with 2,2′-azino-
bis[3-ethylbenzothiazoline-6-sulfonic acid], ABTS, as the en-
zyme reducing substrate), which passed from 2050 s−1 mM−1
in native DyP to only 4 and 1 s−1 mM−1 in the D168N and
R332L variants, respectively. Therefore, other residues con-
tributing to a confined heme pocket in DyP, such as Phe359
(homologous to Phe41 in HRP) and Leu357 (Fig. 1C), were
modified, and the enlarged pocket variants were expressed in
E. coli, in vitro activated, purified to homogeneity (with spe-
cific activities of 400–500 U mg−1 measured with ABTS), and
crystallized, and their sulfoxidation activity was evaluated, as
described below.
Although the L357G variant showed slightly decreased
thermal and pH stabilities (T50 = 59 °C and 50% activity at
pH 9), the F359G variant did not show significantly modified
stability in the range of pH 4–9 (being always higher than
85%) and had only one degree lower T50 (61 °C) than the na-
tive recombinant DyP (62 °C).
Crystal structures of the DyP L357G and F359G vari-
ants. Crystal structures of the L357G (PDB 5IKG) and
F359G (PDB 5IKD) variants were solved at 1.9 and 1.1 Å,
respectively. Their subsequent analysis confirmed that the
overall folding characterizing these enzymes as well as the
position of the heme group were conserved. As expected,
the only changes observed were in the region where muta-
tions were introduced, and basically consisted in the en-
largement of the heme pocket, which was more significant
for the F359G variant (Fig. 2A–C), while the channel open-
ing at the protein surface was wider in the L357G variant
(Fig. 2D–F).
A close-up view of the heme pocket shows an asymmetric
distribution of the cavity according to the volume and posi-
tion of the mutated residue. Thus, in the F359G variant, the
heme pocket is larger allowing the substrate to be properly
positioned, with a potential effect on the stereoselectivity of
sulfoxidation.
Fig. 1 Upper side of the heme pocket in the crystal structures of (A)
HRP (PDB 1ATJ), (B) A. agerita UPO (PDB 2YP1), and (C) A. auricula-
judae DyP (PDB 4W7J) (this heme side is also known as the distal side
due to the presence of the distal histidine of peroxidase–catalases,
His42 in A).
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Sulfoxidation chromatographic and kinetic analyses. Oxi-
dation of MPS and MTS by the A. auricula-judae DyP (native
recombinant protein) and its L357G, F359G, F359W and
F359H variants was followed in time course reactions using
chiral HPLC. Native DyP only produced a small amount of
methyl phenyl sulfoxide, 25% MPS conversion after 6 h incu-
bation, and it did not sulfoxidize the bigger substrate MTS
(Fig. 3). However, the reactions with the heme pocket variants
revealed that L357G and F359G were able to perform sulfo-
xidation with high efficiency. In the case of MPS, 92% conver-
sion and 95% conversion after 30 min reaction were obtained
with the L357G and F359G variants, respectively (Fig. 3A),
while 65% conversion and 99% conversion of MTS under the
same reaction conditions were obtained, respectively
(Fig. 3D). The conversion rates were high (up to 95–99%),
and no additional oxidation products (sulfones) were
detected. The F359W and F359H variants, including changes
that did not enlarge the heme pocket, were unable to sulfo-
xidize any of the two sulfides assayed. Gas chromatography–
mass spectrometry (GC–MS) analyses of reactions using
H2
18O2 (90% isotopic labeling) yielded
18O-sulfoxides (88%
and 79% labeling for MPS conversion with the F359G and
L357G variants, respectively) revealing that sulfoxidation was
a peroxygenation reaction (6% 18O-labeling was found in the
reactions with H2
16O2 in H2
18O buffer).
These long-term incubation experiments were complemented
by estimating kinetic constants for MPS and MTS oxida-
tion under steady-state conditions. F359G showed higher
catalytic efficiency (kcat/Km) than L357G due to 2-fold higher
turnover number (kcat) and lower Km (Table 1). This agrees
with the higher catalytic efficiency of the F359G variant oxi-
dizing the standard substrate ABTS at the heme channel
(1040 ± 80 s−1 mM−1) compared with L357G (175 ± 19 s−1
mM−1). The sulfoxidation catalytic efficiency (and other ki-
netic constants) of F359G DyP is 2–3 orders of magnitude
higher than that of wild-type HRP,11,12 in the same order of
those reported for the best HRP variants,31–34 and lower than
that reported for wild-type CPO (the classic sulfoxidation bio-
catalysts),35 and especially for the recently discovered UPO.20
Interestingly, in the MPS (Fig. 3B and C) and MTS
(Fig. 3E and F) reactions, the enantiomeric production by the
two variants is not the same. L357G produces nearly racemic
mixtures of the methyl-phenyl and methyl-p-tolyl sulfoxides,
while F359G is stereoselectively producing the S sulfoxide.
From these values, enantiomeric excesses (ee) of 92% and
99% were calculated for MPS and MTS oxidation by the
F359G variant, respectively, while the L357G was scarcely
stereoselective, as shown in Table 2. On the other hand,
F359G showed a higher total conversion rate than L357G, in
agreement with its higher catalytic efficiency shown in
Table 1.
Sulfoxidation had been reported for a bacterial
(Thermobifida fusca) DyP, but the conversion was poor (no
rate provided) and the reaction was only slightly selective (61/
49% ee after 36 h reaction with MPS/MTS).36 On the other
hand, improvements in sulfoxidation ability have been
reported by engineering the heme pocket of HRP,31–34 and
CcP.15 These included the W51A and F41L variants, in which
the bulky tryptophan/phenylalanine side chains in the active
sites of CcP and HRP, respectively, were replaced by smaller
groups. This agrees with the present results showing that
Fig. 2 Details of the access channel to the heme pocket (top) and its
opening at the protein surface (bottom) in the crystal structures of the
native DyP (A and D), L357G variant (B and E) and F359G variant (C and
F). In A–C, the heme access channel is shown as cyan meshes and the
heme and neighbor residues as CPK-colored sticks (the two mutated
residues in B and C with red labels), while in D–F an electrostatic po-
tential surface is shown, with the heme as CPK sticks and the removed
side chains in the two variants as gray sticks.
Fig. 3 Results from chiral HPLC analysis of MPS (A–C) and MTS (D–F)
reactions with native DyP and L357G and F359G variants and controls
(C) without the enzyme (after 0, 30, 60 and 360 min incubation)
showing the remaining substrate (A and D) and the resulting R (B and
E) and S (C and F) sulfoxides.
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enlarging the heme pocket of DyP, as found in the F359G var-
iant, resulted in efficient (and stereoselective) sulfoxidation.
Protein engineering has also been reported to improve other
sulfoxidation reactions, such as in the Codexis patent for the
already mentioned production of S omeprazole by a bacterial
monooxygenase.37
Computational analyses
For a deeper inquiry on the atomic mechanistic details re-
sponsible for the observed differences in sulfoxidation
(rate and selectivity) by the native DyP and its two vari-
ants, we turned to molecular modeling using the crystal
structures solved in this work, as described in the next
two sections.
Ligand diffusion energy profiles. When analyzing both the
interaction energies and the substrate–heme distances (from
the compound I oxygen to the sulfur atom of the substrates),
protein energy landscape exploration (PELE) simulations
show a more favorable protein–substrate catalytic complex
for the two variants. In L357G and F359G (Fig. 4B and C, re-
spectively), we find a considerable number of structures be-
low 4 Å (which we consider to be optimal for the reaction)
with better interaction energies, with respect to the native en-
zyme (Fig. 4A).
Moreover, we see a higher number of trajectories at cata-
lytic distances for those conditions where we observe over
90% conversion in 30 min: F359G reaction with MTS and
MPS and L357G reaction with MPS. Notice that although in
native-DyP MPS interaction energies are quite favorable, the
ligand is positioned too far from the heme. These differ-
ences in the energy profiles, which indicate an unfavorable
ligand–protein interaction and ligand positioning on native
DyP, can explain its undetectable (on MTS) or very low (on
MPS) activity, which was only observed in long-term incuba-
tion experiments.
Selectivity. To investigate the observed stereoselectivity of
the sulfoxidation reaction, a study of the pro-R and pro-S po-
sitioning tendency for MPS and MTS was performed. For this,
PELE structures from the lowest 10 kcal mol−1 interaction en-
ergies and with distances to the heme below 5 Å were se-
lected (different criteria to select PELE structures did not sig-
nificantly change the results). Then, the O–S–C1–C2 dihedral
angles were extracted (Fig. 5), and all structures were classi-
fied into potential pro-R, pro-S or mixed pro-R/S poses.
First, it should be mentioned that there was a higher
number of structures in a good position towards the heme
and with an optimal energy to react in the F359G variant
than in L357G, in agreement with the higher catalytic
Table 1 Kinetic constants – kcat (s
−1), Km (mM) and kcat/Km (s
−1 mM−1) – for MPS and MTS sulfoxidation with native DyP and two directed variants (means
and 95% confidence limits)
MPS MTS
kcat Km kcat/Km kcat Km kcat/Km
DyP 0 — — 0 — —
L357G 8.0 ± 0.5 0.60 ± 0.08 13.3 ± 1.0 0 — —
F359G 17.2 ± 0.9 0.37 ± 0.01 45.9 ± 7.4 3.6 ± 0.4 0.13 ± 0.03 26.5 ± 3.8
Table 2 Chiral HPLC analysis of MPS and MTS reactions (30 min) with
native DyP and two directed variants
MPS MTS
Conversion
(%) Isomer ee (%)
Conversion
(%) Isomer ee (%)
DyP 0 — —a 0 — —
L357G 92 S 2 65 R 8
F359G 95 S 92 99 S 99
a Only 25% conversion of MPS by DyP after 360 min with 42% ee of
the S isomer.
Fig. 4 Interaction energies (in kcal mol−1) vs. ligand distances (in Å)
from PELE simulations for MPS (left) and MTS (right) substrates in the
(A) native DyP, (B) L357G variant, and (C) F359G variant. The distances
are between the reactive O atom in the heme compound I and the
sulfur (S) atom of the substrates; each color corresponds to a different
trajectory. The structures used for the selectivity analysis are delimited
with a red box.
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efficiency of the phenylalanine variant. The L357G and, espe-
cially, the F359G mutations cause a binding site enlargement,
which improves MPS and MTS positioning in comparison
with native DyP, as shown by PELE.
Fig. 6 shows the different pro-R (cyan) and pro-S (green)
positions for the native DyP and F359G, the best variant. In
DyP, the presence of large (and bulky) residues (Arg332,
Leu357 and Phe359) in the heme pocket hinders the proper
positioning of both MPS and MTS substrates. Otherwise, for
the two mutant proteins, we find an easier positioning of the
substrate ring, in correlation with the binding energy analysis
shown above. However, contrary to experimental results, sub-
strates on both DyP variants show a preference to adopt pro-
R positions, even though pro-S and pro-R/S positions are also
possible.
To clarify this apparent contradiction with the experimen-
tal results, substrate spin densities were computed with
quantum mechanics/molecular mechanics (QM/MM) calcula-
tions on the best (substrate) positioned structures. The spin
density originates from substrate oxidation, which directly
correlates with sulfoxidation.38,39 In addition to having better
protein–ligand interaction energies, as described above, the
DyP variants showed a significantly larger spin density than
the native DyP, again confirming the improvement in cata-
lytic activity upon mutation. Moreover, in the F359G variant,
we observe a substantial difference between the spin density
values for the two enantiomers provided in Fig. 6, which
might discriminate against the R enantiomer oxidation.
Thus, even though a higher percentage of structures are
placed favoring the formation of an R enantiomer, pro-S
structures are more easily oxidized, which would explain the
S stereoselectivity experimentally observed for this variant. In
agreement with the racemic mixture seen experimentally for
the L357G variant, we see a higher relative frequency of the
pro-R/S position for L357G compared to F359G (Fig. S1A†).
Interestingly, changes in spin density, associated with the
different enantiomers, correlate with the position adopted by
the substrate with respect to Arg332. Mutations induce a
change in the positioning of the ligand that leads to a closer
interaction of the pro-R structures with this arginine residue
(Fig. 7). As seen in previous publications,40 the electrostatic
environment changes caused by this positive charge could
lead to an altered substrate oxidation. This effect is larger in
the F359G variant, where differences in spin density are more
pronounced, while L357G results do not show a significant
population of the pro-S conformer at large distances (Fig.
S1B†). The correlation between the substrate spin density
and its charge distribution was further verified by QM/MM
calculations on 10 selected structures with different charge
distribution (Fig. S2†).
In connection with the above computational results, im-
provement in the HRP sulfoxidation ability has been reported
by removing the distal arginine residue (Fig. 1A).33 A similar
change is not possible in DyP engineering, since Arg332
(Fig. 1C) is necessary for DyP activation by H2O2, the catalytic
Fig. 5 R/S enantiomer classification criterion. The Φ dihedral is
computed from the compound I catalytic oxygen (O) atom and
substrate S and carbon C1 and C2 atoms. When Φ is between 40° and
140°, the substrate is classified as pro-R, and when Φ is between −40°
and −140°, it is classified as pro-S. Otherwise, the substrate is
considered to be able to form both R and S enantiomers equally.
Fig. 6 Substrate positioning at the heme pocket: A) pro-R and pro-S
MPS (left) and MTS (right) positioning on native DyP. B) Pro-R and pro-
S MPS (left) and MTS (right) positioning on the F359G variant. Pro-S
and pro-R substrate positions are shown as CPK sticks with the C
atoms in green and cyan color, respectively. The spin density
population on the substrate, from QM/MM calculations, is indicated in
each image.
Fig. 7 Frequency–distance (in Å) distribution of MPS and MTS S atom
to Arg332 CZ atom on the F359G variant for the selected reactive
structures: last 10 kcal mol−1 interaction energies and distances to the
heme below 5 Å. Histograms for pro-R structures are shown in cyan,
for pro-S structures in green, and for pro-R/S structures in grey.
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efficiency being 2000-fold lower in the R332L variant, as
shown above.
Conclusions
Stereoselective sulfoxidation ability could be introduced in a
model (robust) peroxidase (A. auricula-judae DyP) by directed
mutagenesis of residues at the distal side of the heme cofac-
tor. The best variant (F359G) converted 95–99% MPS and
MTS into the corresponding sulfoxides in 30 min reactions
yielding the S enantiomer with 90–99 ee. The crystal structure
of the F359G variant revealed an enlarged heme pocket en-
abling better accommodation of the sulfide substrates near
the Fe4+O of the activated heme cofactor, whose oxygen
atom is transferred to the sulfide substrate as shown by 18O-
labeling (in H2
18O2 reactions).
Computational modeling, based on the crystal structures
of the parent enzyme and several variants, showed that the
sulfoxidation ability of the F359G variant (no reaction was
produced by the parent enzyme) is due to better substrate ac-
cess (closer distance) to the reactive cofactor with better
interaction energies, as shown by the PELE software. More-
over, the sulfoxidation stereoselectivity could be rationalized
by QM/MM calculations predicting a higher reactivity of the
sulfide molecules adopting pro-S poses at the active site
(which was affected by a heme pocket arginine residue).
The study also demonstrates how molecular simulations
can help obtain the required oxidation yields and stereo-
selectivities in sulfoxidation engineering.
Materials and methods
Chemicals
Hexane (HPLC quality), 4′-methoxyacetophenone, methyl-
phenyl sulfoxide, R-(+)-methyl-p-tolyl sulfoxide, R/S methyl-p-
tolyl sulfoxide, MPS and MTS were from Sigma-Aldrich. Iso-
propyl alcohol (LC-MS quality) was from Fluka.
Dichloromethane (HPLC quality) was from Merck.
Directed mutagenesis
Simple DyP variants were produced by PCR using the
pET23a-DyPI vector harboring the mature protein-coding se-
quence of A. auricula-judae DyP as a template.24 For each mu-
tation, a direct primer and a reverse primer were designed
complementary to opposite strands of the DNA region
containing the desired mutation. The sequences of the direct
primers (with the mutated codons in italics) used for muta-
genic PCR were the following: D168N mutation, 5′-G TTC
GGC TTC CTT AAC GGA ATT GCT CAG CC-3′; R332L muta-
tion, 5′-GCT AAC TCT ATC ATG CTC AGC GGC ATC CC-3′;
L357G mutation, 5′-CT CAG GAG CGC GGC GGA GCG TTT
GTG GCA TAC-3′; F359G, F359H or F359W mutations, 5′-GGC
CTT GCG (GGA, CAC or TGG, respectively) GTG GCA TAC-3′.
PCR reactions were carried out in an Eppendorf (Ham-
burg, Germany) Mastercycler Pro using 10 ng of template
DNA, 250 μM of each dNTP, 125 ng of direct and reverse
primers, 2.5 units of polymerase (Expand Long Template PCR
System), and the manufacturer's reaction buffer. Reaction
conditions were as follows: i) a “hot start” of 95 °C for 1 min;
ii) 18 cycles at 95 °C for 50 s, 55 °C for 50 s, and 68 °C for 10
min; and iii) a final cycle at 68 °C for 10 min. The mutated
sequences were confirmed by DNA sequencing using an ABI
3730 DNA analyzer (Applied Biosystem). pET23a-DyPI plas-
mids containing the mutations described above were
digested with endonuclease DpnI and transformed into E.
coli DH5α for propagation.
Enzyme production
E. coli BL21ĲDE3)pLysS cells with the pET23a-DyPI vector
containing the A. auricula-judae mature DyP sequence (and
those of DyP variants) were grown overnight at 37 °C and 170
rpm in Luria Bertani broth (with 100 μg mL−1 ampicillin and
34 μg mL−1 chloramphenicol) and used to inoculate 2 L
flasks containing 1 L of Terrific Broth (TB) (with 100 μg mL−1
ampicillin and 34 μg mL−1 chloramphenicol) that were grown
for 3 h at 37 °C and 200 rpm, induced with 1 mM isopropyl-
β-D-thiogalactopyranoside, grown for further 4 h, and
harvested by centrifugation. The apoenzyme, accumulated in
inclusion bodies, was solubilized in 50 mM Tris-HCl (pH 8.0)
containing 8 M urea, 1 mM EDTA, and 1 mM dithiothreitol
for 1 h at 4 °C. In vitro activation of the native DyP and its
D168N, R332L and L357G variants was carried out as previ-
ously described,24 and specific activities were determined
using 7.5 mM ABTS as a substrate and 2.5 mM H2O2.
For the three Phe359 variants, in vitro activation was
performed at 4 °C using 0.15 M urea, 10 μM hemin, 0.02
mM dithiothreitol, 0.4 mM GSSG, 20% glycerol, 0.1 mM
EDTA and 0.1 mg mL−1 protein in 50 mM phosphate (pH
6.5). After 144 h, the folding mixture was concentrated using
a Millipore Pellicon ultrafiltration system (10 kDa cutoff) and
centrifuged for 18 h at 13 000 rpm. Once concentrated, sam-
ples were dialyzed against 20 mM sodium acetate (pH 4.3),
and the insoluble material was eliminated by centrifugation
(13 000 rpm, 30 min).
Active DyPs (native enzyme and four directed variants)
were purified using a Resource Q column (GE Healthcare)
coupled to an ÄKTA liquid chromatography system, using a
gradient from 0 to 0.3 M NaCl in 10 mM Tris-HCl, pH 7 (15
min, 2 mL min−1). DyPs were analyzed by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis to confirm the pu-
rity of the proteins. The absorption spectra were recorded in
10 mM sodium tartrate (pH 5) at 25 °C using a Thermo
Spectronic diode-array spectrophotometer. The DyP molar ab-
sorption coefficient (ε405 117 000 M
−1 cm−1) was used for pro-
tein concentration determination.
Enzyme kinetics
Steady-state kinetic studies were performed by measuring the
initial rates for MPS and MTS oxidation at 25 °C in 100 mM
acetate, pH 5 (in triplicate). A 500 mM MPS and MTS stock in
ethanol was serially diluted in ethanol to obtain final
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substrate concentrations from 250 mM to 2 mM. 10 μl of
substrate were used to measure activity in 1 mL of reaction,
in 1 cm light path cuvettes (when the initial absorbance
was greater than 1, 0.33 mL reactions in 0.1 cm light path
cuvettes were performed). 200 nM and 100 nM concentra-
tions of native DyP and its mutated variants were used, re-
spectively, and the reactions were started by adding 2 mM
H2O2. The initial rates (absorbance decrease) were calcu-
lated using the differences in the molar absorption coeffi-
cients (Δε) of MPS and methyl-phenyl sulfoxide (Δε254 7870
M−1 cm−1) and MTS and methyl-p-tolyl sulfoxide (Δε253 8040
M−1 cm−1).41 Kinetic constants for H2O2 reduction and ABTS
oxidation were estimated by following the formation of the
ABTS cation radical (ε436 29 300 M
−1 cm−1). In the former
case, a saturation concentration of ABTS (7.5 mM for native
DyP and the L357G variant and 2.5 mM for the D168N,
R332L, F359G, F359H and F359W variants), 10 nM enzyme,
and different concentrations of H2O2 (from 20 μM to 25
mM) in 100 mM tartrate, pH 3, were used, while in the sec-
ond case oxidation of different ABTS concentrations, in the
presence 2.5 mM H2O2, was measured. Plotting and analysis
of kinetic curves were carried out using SigmaPlot 11.0. Ap-
parent affinity, turnover number and catalytic efficiency
were estimated by non-linear least-squares fitting to the
Michaelis–Menten model.
Chromatographic analyses
Reactions (at 25 °C) were performed using 2 mL of 50 mM so-
dium acetate (pH 5) containing substrate (1 mM MPS or 0.5
mM MTS), 4 μM enzyme, and 1 mM H2O2. At 0, 30, 60 and
360 min of reaction, 0.5 mL aliquots were taken, and after
addition of 4′-methoxyacetophenone as internal standard, the
solution was extracted with hexane and analyzed by chiral
HPLC.
The reaction products were analyzed using an Agilent
HPLC equipment fitted with a Chiralpack IB column (dimen-
sions of 4.6 mm × 250 mm and particle size of 5 μm) and as
a mobile phase isocratic hexane : isopropyl alcohol (95 : 5, v/v)
for 40 min for analysis of reactions with MPS and 98 : 2 (v/v)
for 70 min for reactions with MTS, at a flow rate of 1 mL
min−1, at room temperature. Elution was monitored at 207,
216, 237, 248 and 263 nm. Calibration curves were obtained
for identification and quantification of substrates and their
sulfoxidation products. The retention times for the R (62
min) and S (64 min) methyl-p-tolyl sulfoxides were obtained
from the corresponding standards, while those for the R (31
min) and S (33 min) methyl-phenyl sulfoxides were obtained
from enzymatic oxidation of MPS assuming the published
elution order,42 which coincided with that observed for the
two methyl-p-tolyl sulfoxides.
Enzymatic reactions with 18O-labeled hydrogen peroxide
(H2
18O2, 90% isotopic content, 2% w/v solution) and water
(H2
18O, 97% isotopic content) from Sigma-Aldrich were
performed under the same conditions, extracted with
dichloromethane, and analyzed by GC-MS using a gas chro-
matograph equipped with an HP-5MS column (Agilent, Santa
Clara, CA, USA; 30 m × 0.25 mm internal diameter; 0.25 μm
film thickness) coupled to a quadrupole mass detector.
Helium was used as the carrier gas, and the oven program
started at 110 °C for 2 min and increased at 20 °C min−1 until
240 °C. 18O-labeling was calculated as the ratio between the
abundances of the 18O- to 16O sulfoxide peaks, in their molec-
ular ion (m/z 142 and 140, respectively, in the MPS reactions)
chromatograms.
pH and temperature stability
The pH stability of the L357G and F359G variants and the
native recombinant DyP was determined by incubating the
enzymes (1 μM) for 24 h in 50 mM Britton–Robinson
buffer (pH 2–12) at 25 °C. To evaluate their temperature sta-
bility, the enzymes in 10 mM sodium tartrate (pH 5) were in-
cubated in the range from 25 to 80 °C for 10 min, followed
by 2 min at 4 °C. The remaining activities were measured (in
triplicate reactions) using 2.5 mM ABTS in 100 mM sodium
tartrate (pH 3), as described above. The activity immediately
after adding the enzyme to the buffer was taken as 100%.
The T50 values, defined as the temperature at which 50% of
activity is lost in 10 min incubation, were calculated.
Crystallization, data collection and refinement
Crystallization of the L357G and F359G variants was
performed in 96-well sitting drop plates (Swissci MRC, En-
gland) at 22 °C using a Cartesian Honeybee robot (Digital,
USA) and commercially available kits: JBScreen Classic (Jenna
Bioscience, Germany), Wizard Classic Screen (Emerald Bio-
structures, USA) and ProPlex HT-96 (Molecular Dimensions,
UK). Each droplet was 0.4 μL in size, containing 0.2 μL of
protein (3 μg) solution and 0.2 μL of precipitant and was
equilibrated over 50 μL of reservoir solution. Crystals of the
L357G mutant were obtained in 5% MPD (v/v), 100 mM MES
(pH 6.5) and 15% PEG 6000 (w/v). For the F359G variant, crys-
tals were obtained in 2 M magnesium formate and 20% PEG
3350 (w/v). Crystals were cryoprotected using Paratone-N
(Hampton Research).
X-ray diffraction images were collected at the ESRF (Gre-
noble, France) and ALBA (Barcelona, Spain) synchrotrons.
Diffraction data were processed using XDS43 and scaled using
AIMLESS.44,45 The structures were solved by molecular re-
placement using PHASER,46 with the A. auricula-judae native
DyP (PDB 4W7J) as the search model. The initial model was
first refined with REFMAC5 (ref. 47) and alternating manual
building with COOT.48 The final model was obtained by re-
petitive cycles of refinement using PHENIX.46 Subsequent re-
finement, introduction of solvent molecules and structure
validation were as described for the native DyP26 (data collec-
tion, refinement and final statistics of the two DyP variants
are summarized in Table S1†).
The L357G structure did not show electron density for the
first residue at the N-terminus, but the whole sequence could
be solved for the F359G variant. In contrast, the C-terminal
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region showed good electron density for both structures. The
coordinates and structure factors have been deposited in the
Protein Data Bank.
System preparation for molecular modeling
The starting structures for the computational simulations
were the native DyP crystal at a resolution of 1.79 Å (PDB
4W7J)26 and the crystal structures of the L357G and F359G
variants (PDB 5IKG and 5IKD, respectively). Protein struc-
tures were prepared accordingly under pH 5 conditions, opti-
mal for MPS and MTS sulfoxidation, using Schrödinger's Pro-
tein Preparation Wizard,49 and the H++ web server.50 Under
these mild acidic conditions, histidines were double-proton-
ated, with the exception of His-115 (ε-protonated) and His-
304 (δ-protonated), and all other acidic residues were
deprotonated. The heme site was modeled as thiolate-ligated
compound I after being fully optimized in the protein envi-
ronment with quantum mechanics/molecular mechanics
(QM/MM) using QSite (see below for the level of theory).51 Fi-
nally, MPS and MTS molecules were optimized with Jaguar,52
at the density functional theory (DFT) M06 level with the
6-31G** basis set and Poisson–Boltzmann Finite element
(PBF) implicit solvent in order to obtain their electrostatic po-
tential atomic charges.
PELE computational analysis
Once the protein structures had been prepared and ligands
optimized, heme binding site exploration was performed with
PELE, a Monte Carlo-based algorithm capable of effectively
sampling the protein–ligand conformational space.53,54 The
substrates were placed manually in identical positions at the
entrance of the heme-access channel of each protein. PELE
simulations were carried out in two stages: first, ligands were
requested to move from the solvent to the heme site, and
once the center of mass of the ligand was within 5 Å of the
heme catalytic oxygen, it was free to explore the active site
pocket with a 15 Å restrain. The results presented here are
based on 240 trajectories × 48 h for each ligand.
QM/MM simulations
Hybrid QM/MM calculations were carried out in order to in-
vestigate the mutation effect on substrate sulfoxidation.
PELE minima snapshots of MPS and MTS substrates on na-
tive DyP, L357G and F359F variant binding sites were se-
lected for quantum calculations. For each case, at least two
structures were investigated: a structure with the ligand in
an optimal orientation toward the heme reactive oxygen to
produce an R-(−)-sulfoxide product and a structure with the
ligand placed correctly to give an S-(+)-sulfoxide product. QM/
MM calculations were performed by including the heme
(modeled as compound I), its axial ligand and the substrate
in the quantum region and computing the spin density. In
order to prepare the system for QM/MM, 0.5 ns molecular
dynamics were performed with Desmond,55 using SPC (sim-
ple point charge) solvent and an ionic force of 0.15 M. Calcu-
lations were performed at the DFT M06-LĲlacvp*)/OPLS level
with QSite.52
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